KVA12123,Pembrolizumab
kineta bio,Merck
['biomarker', 'kva12123']
$ka - kineta unveils new vista biomarker data and kva12123 phase 1/2 clinical trial update at aacr annual meeting 2023 
Follow for the latest #healthcare #stockmarket tweets. Visit https://t.co/wA5OfUn0Ee to try our powerful investing tools.